Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. THIRD AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • November 8th, 2007 • NMT Medical Inc • Surgical & medical instruments & apparatus • Massachusetts
Contract Type FiledNovember 8th, 2007 Company Industry JurisdictionThis Third Amended and Restated Employment Agreement (the “Agreement”) is effective as of the 18th day of October, 2007 (the “Effective Date”), by and between John E. Ahern (the “Executive”) and NMT Medical, Inc., a Delaware corporation (the “Company”).
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • December 14th, 2005 • NMT Medical Inc • Surgical & medical instruments & apparatus • Massachusetts
Contract Type FiledDecember 14th, 2005 Company Industry JurisdictionThis Second Amended and Restated Employment Agreement is effective as of the 13th day of December, 2005, by and between John E. Ahern (the “Executive”) and NMT Medical, Inc., a Delaware corporation (the “Company”).
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • August 10th, 2004 • NMT Medical Inc • Surgical & medical instruments & apparatus • Massachusetts
Contract Type FiledAugust 10th, 2004 Company Industry JurisdictionThis Amended and Restated Employment Agreement (the “Agreement”) is entered into as of May 20, 2004, by and between Richard E. Davis (the “Executive”) and NMT Medical, Inc., a Delaware corporation (the “Company”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 20th, 2003 • NMT Medical Inc • Surgical & medical instruments & apparatus • Massachusetts
Contract Type FiledMarch 20th, 2003 Company Industry JurisdictionThis Amended and Restated Employment Agreement is effective as of the 31st day of December, 2002, by and between John E. Ahern (the “Executive”) and NMT Medical, Inc., a Delaware corporation (the “Company”).